MOONLAKE IMMUNOTHERAPEUTICS Public Float
MOONLAKE IMMUNOTHERAPEUTICS (MLTX) had Public Float of $1.34 billion as of 2025-06-30, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-25
- 2025-06-30: Entity Public Float $1.34B.
- 2024-06-30: Entity Public Float $1.14B.
- 2023-06-30: Entity Public Float $1.12B.
- 2022-06-30: Entity Public Float $33.72M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $1.34B 10-K · filed 2026-02-25 |
| 2024-06-30 | $1.14B 10-K · filed 2025-02-26 |
| 2023-06-30 | $1.12B 10-K/A · filed 2024-05-07 |
| 2022-06-30 | $33.72M 10-K · filed 2023-03-20 |
| 2021-06-30 | $119.03M 10-K · filed 2022-02-17 |
| 2020-06-30 | $0.00 10-K/A · filed 2021-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |